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Background to the debate: The UK Medical Research
Council defines complex interventions as those com-
prising ‘‘a number of separate elements which seem
essential to the proper functioning of the interventions
although the ‘active ingredient’ of the intervention that
is effective is difficult to specify.’’ A typical example is
specialist care on a stroke unit, which involves a wide
range of health professionals delivering a variety of
treatments. Michelle Campbell and colleagues have
argued that there are ‘‘specific difficulties in defining,
developing, documenting, and reproducing complex
interventions that are subject to more variation than a
drug’’ [10]. These difficulties are one of the reasons why
it is challenging for researchers to systematically review
complex interventions and synthesize data from sepa-
rate studies. This PLoS Medicine Debate considers the
challenges facing systematic reviewers and suggests
several ways of addressing them.
Viewpoint of Sasha Shepperd, Simon Lewin,
Sharon Straus, Mike Clark, Martin Eccles, and Ray
Fitzpatrick: We Must Address the Conceptual and
Analytical Challenges in Synthesising Studies of
Complex Interventions
Background
Over the last two decades, the application of randomised
controlled trials and systematic reviews has extended to the
evaluation of ever more complex interventions. A range of facets of
the complexity of these interventions has been identified. While
most health care interventions have some degree of complexity,
interventions that include a number of components, which may be
independent or inter-dependent, are at the more complex end of
the spectrum [1]. Examples include case management and
discharge planning, both of which aim to minimise the
fragmentation of health care [2,3]. More recently, complex
interventions of a more conceptual nature have been systemati-
cally reviewed, such as continuity of care or ‘‘trust’’ between
doctors and patients [4,5]. These present the additional challenge
of defining concepts that are often poorly developed.
Compared with single evaluations of complex interventions
[1,6], less attention has been paid to the methodological issues
arising from the synthesis of data from complex interventions.
Important limitations include difficulties in (1) defining the
intervention within the review; (2) searching for and locating
relevant evidence; (3) standardising the selection of studies for a
review; and (4) synthesising data. In this Viewpoint, we describe
the implications of these limitations and suggest some approaches
to help systematic reviewers reflect on the conceptual and
analytical challenges posed by these types of review.
1. Defining the Complex Intervention
To varying degrees, complex interventions can be standardised
and defined in individual prospective studies. However, the lack of
an agreed definition of complex interventions that have the same
aim but are described differently, or inadequately, across studies
poses inherent difficulties for systematic reviewers and users of
these reviews [7]. Case management illustrates this well. Despite
there being no agreed typology, case management has become a
generic concept across different specialities to improve inter-
professional collaboration and co-ordination of care for individual
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patients. Case management comes in many forms, including a
brokerage model, an integrated care pathway, a liaison service,
and self-managed care [2]. All these variations can occur alone or
in combination.
Defining the intervention is made difficult when the core
purpose of an intervention, such as behavioural counselling [8],
varies according to the characteristics of the participants or the
trial setting, or if the intervention aims to promote an abstract
concept, such as promoting trust or continuity of care [4,5]. In the
field of service delivery, interventions become complex and
difficult to define if, as is often the case, (1) they are delivered
across the primary-secondary care interface; (2) they are delivered
in new settings; or (3) there is an added behavioural dimension and
staff perform new behaviours or current behaviours in a new
context [9].
Solutions to improve the description and conceptual under-
standing of the content of a complex intervention include (1)
typologies to guide the classification of interventions and (2)
supplementary evidence, such as qualitative or descriptive data
[10,11] (see Table 1).
A. Typologies. Typologies can guide the classification of
common elements of interventions into homogeneous groups. The
Cochrane Effective Practice and Organisation of Care Review
Group (EPOC) has developed a typology for interventions aimed
at professional practice, organisational, financial, and regulatory
systems (see http://www.epoc.cochrane.org/). The Cochrane
Consumers and Communication Review Group has developed a
typology for consumers’ interactions with health care professionals,
services, and researchers (see http://www.latrobe.edu.au/chcp/
assets/downloads/TopicList.pdf). As an example of how such
typologies are used, the EPOC typology was used to classify
quality improvement strategies designed for the care of people
with type 2 diabetes [12]. Subsequent correspondence highlighted
the risk of misclassifying interventions due to inadequate detail
[13]. In another example, a typology for heart failure disease
management guided the grouping of clinical service interventions
(multi-disciplinary, case management, and clinic models) [14,15].
An alternative is to develop a typology of interventions by
consensus. For example, in a systematic review of occupational
therapy interventions for rheumatoid arthritis, four occupational
therapists identified seven types of intervention (comprehensive
therapy, training of motor function, skills training, joint protection,
advice on assistive devices, counselling, and provision of splints) [16].
B. Supplementary evidence: (i) Trial-related data. Con-
tacting trialists to obtain the protocols they followed, and
identifying supplementary research related to the trial, may help
Table 1. Identifying the key components of a complex intervention for a systematic review.
Solutions
Examples of Where These
Techniques Have Been Used
Is This Prospective or
Retrospective?
Additional
Data
Required Comments
1. Typologies of the structural
characteristics of a complex
intervention
Application of the EPOC taxonomy
of professional, organisational, and
financial interventions to classify
quality improvement strategies
designed to improve the care of
those with type 2 diabetes [12]. In
another example, the interpretation
by pre-review consensus identified
seven categories of occupational
therapy intervention for rheumatoid
arthritis [16].
Prospective at the review
stage.
No Few typologies exist as this is an evolving
field and existing typologies are relatively
untested; misclassification can occur [13];
and the mechanism of action for many
interventions remains poorly understood
[34]. Employing the expertise of those
working in the field provides face validity
to the categorisation; this is a method
that could be applied relatively easily, but
problems could occur if consensus is not
reached; the results may not be
comprehensive.
2. Trial-related data (trial
protocols, supplementary studies)
A survey of trialists contributing to a
systematic review of stroke units to
identify the key attributes of the
intervention [18]. In another example,
trialists were contacted for their
definition of peer support in a review
of peer support telephone calls for
improving health [35].
Can be prospective [17,36]
or retrospective [18].
Yes Few examples of supplementary studies
to develop intervention typologies [19];
may be problems in generalising the
results of these studies across the review.
3. Policy documents Policy supporting the adoption of a
complex intervention can explain
subtle differences in the way
interventions have been designed
and implemented.
Prospective while drafting
the protocol for the review.
Yes Can be difficult to identify the policy
documents that correspond to the
development of an intervention,
particularly as systematic reviews are of
the world literature; interventions may
not have been developed in response to
a particular policy change.
4. Alternative sources of data
(qualitative, descriptive) to guide
the categorisation of interventions
A qualitative synthesis guided the
categorisation of interventions aimed
at promoting healthy eating among
children and the exploration of
heterogeneity [21].
Carried out in parallel with
the systematic review of
quantitative data.
Yes A major limitation is the lack of related
data [19]; the process is resource
intensive and adds another layer of
complexity to an already labour-intensive
process.
5. Theoretical basis of an
intervention
Interventions designed to implement
change in practice were categorised
according to their theoretical
construct [27].
Prospective at the review
stage.
No Theory has seldom been used explicitly to
guide intervention development. There
are a large number of theories and the
empirical basis for many of the behaviour
theories remains limited [34].
doi:10.1371/journal.pmed.1000086.t001
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define interventions. A qualitative study, conducted alongside a
trial of intensive case management for people with severe mental
illness, investigated the active ingredients of the intervention in
terms of staff roles and organisational features [17]. Team
management, comprehensive assessment, and needs-led service
were regarded as the key mechanisms of this intervention. In
another example, trialists contributing to a systematic review of
stroke units were surveyed to build a description of the active
components of stroke unit care. These included comprehensive
assessment, active physiological management, early mobilisation,
skilled nursing care, early rehabilitation, and discharge planning
involving carers [18].
B. Supplementary evidence: (ii) Qualitative data,
descriptive data, and policy documents. When trial-related
evidence is inadequate [19], other sources of information may be
relevant [20]. A systematic review of barriers and facilitators to
healthy eating among children used qualitative evidence,
unrelated to the trial data, to gain a better understanding of
children’s perspectives [21]. The qualitative synthesis guided the
categorisation of interventions, according to the degree to which
they combined health advice with the promotion of eating fruit
and vegetables. A synthesis of qualitative studies aided a fuller
understanding of the interventions included in a systematic review
of directly observed therapy (DOT) for tuberculosis, by identifying
factors that improved adherence [22]. Factors included flexible
delivery systems, involving patients in decisions, and social and
family support systems [23]. Policy documents can be particularly
informative in understanding the development of service
interventions across settings, for example, interventions designed
to reduce reliance on hospital beds and interventions involving
school feeding programmes [24,25].
B. Supplementary evidence: (iii) Theory. Theory may
help to explain how an intervention is related to similar
interventions in a particular field [26]. However, many reviews
fail to locate interventions within a theoretical model. Realist
synthesis, which attempts to provide an explanatory analysis of
how and why complex social interventions work (or not) in
particular contexts, can aid this process. For example, a realist
review of school feeding programmes identified the theory and
processes that promoted the success of these interventions [25].
Theory can also guide the classification of interventions;
behavioural and contingency theory successfully guided the
classification of interventions designed to implement change in
practice [27]. The theory of planned behaviour was used to
address an individual’s motivation, attitude, and perceived
behavioural control; whereas contingency theory was used to
take into account the fit between clinical practice and
environmental constraints. However, theory can only improve
our understanding of how an intervention works if it is part of an
integrated body of knowledge that differentiates the explanatory
role of one theory from another and provides robust predictions of
causal pathways. An attempt to categorise studies in a Cochrane
review of tobacco cessation for young people failed due to the
complexity of the interventions and the simultaneous use of several
psychosocial theories [28].
2. Searching For and Identifying All Relevant Data
The lack of consistent terminology and the inconsistent use of
existing terminology to describe complex interventions means that
identifying potentially eligible studies can be difficult. Search
strategies may be incomplete and risk introducing bias if they
identify only a proportion of all possible configurations of a
complex intervention. For example, ‘‘continuity of care’’, a
concept that is considered to contribute to high-quality care, can
be delivered through numerous mechanisms (shared care,
telephone follow-up, patient-held records, and case management,
to name a few) [29].
Solutions include characterising the elements of an intervention
through an iterative scoping exercise and searching outside the
traditional health care domains to include engineering, social
sciences, and management journals. Data may be unpublished and
only accessed through policy documents, conference proceedings,
or book chapters, but need to be obtained to minimise the effects
of publication bias [30,31]. Contacting those working in the field,
retrieving references of references, and tracking citations will also
increase the efficiency of finding relevant evidence.
3. Selecting Studies for Inclusion in a Review
A major threat to validity from an imprecise definition of an
intervention is the non-standardised and potentially non-repro-
ducible selection of studies for inclusion in a review. Based on the
available information, considerable judgement may be required
when assessing how similar any given intervention is to the
intervention of interest, particularly for multi-faceted interventions
and those at the boundary of the content area. For example,
reaching a common understanding of patient-centred interven-
tions was not easily achieved in a review of interventions intended
to promote patient-centred care [32].
Solutions to this problem of definition include: (1) refining the
definition of an intervention through an iterative process to
accommodate previously unseen configurations; (2) contacting
study authors for further information; (3) recording the compo-
nents of an intervention during data extraction; and (4) being
explicit in the review about where disagreement occurred.
4. Synthesis of Data
Complex interventions with a large number of ill-defined
elements may result in a high degree of heterogeneity. Conversely,
applying a narrow definition limits generalisability by losing the
potential relevance gained from examining an intervention being
implemented across a range of settings. A meta-analysis of DOT
for tuberculosis provided in clinics, by lay health workers, or in the
home provides an example of the usefulness of exploring sources of
heterogeneity [22]. The authors found no important difference
between DOT and self-administered treatment (risk ratio 1.02,
95% confidence interval 0.86 to 1.21; I2 64%). However, when the
trials were grouped by the location of DOT there was a small
beneficial effect for delivering DOT in a home setting compared
with self administration (risk ratio 1.10, 95% confidence interval
1.02 to 1.18; I2 53%). This beneficial effect allows for several
possible interpretations; for example, the burden upon patients of
travelling to a clinic five days a week is minimised by having their
therapy supervised at home by a lay health worker or a
community or family member.
Solutions to the problem of data synthesis include categorising
interventions by key variables and retaining these in the analysis.
For example, a meta-analysis of discharge planning and post-
discharge support categorised interventions by intensity, which
varied from a single home visit, to increased clinic follow-up with
telephone contact through to extended home care services [3]. If
meta-analyses cannot be performed, similar processes can be
conducted whilst performing narrative synthesis. The quality of
narrative analysis and applicability of review findings have recently
received more attention [33] (see Box 1).
Conclusion
Despite the range of supplementary methods available to
improve the synthesis of complex interventions, most of these
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methods are infrequently used. There are several reasons for this
lack of use. In some cases the theory underpinning a specific
complex intervention has not been assembled. However, there are
usually few data reporting the characteristics of complex
interventions, and what data there are tend to be of poor quality.
Although simple in concept, providing an adequate description of
complex interventions can be technically difficult. The need to
address this is becoming urgent as interventions with multiple
components evolve in response to the complex health problems
faced by health services. Current criteria to improve the reporting
of health research are primarily concerned with the internal
validity of studies [6], and while these include criteria related to
the intervention, these guidelines can still be followed without
providing adequate details of the intervention (see Table 2). It is
essential that methods to improve the descriptions of complex
interventions are further developed and tested with the expecta-
tion that they will complement existing systematic review
methodology.
Geoff Wong’s Viewpoint: We Must View Complex
Health Interventions in a New Way
I believe that complex health interventions (CHIs) can be
systematically reviewed, but only if a paradigm shift occurs in the
way that these interventions are conceptualised. In this Viewpoint, I
discuss an alternative way of viewing CHIs that focuses on the
interactions between components of a CHI and the impact of
human behaviour on the outcome of the intervention. I then discuss
how this different way of viewing CHIs has given rise to a different
method, called ‘‘realist review’’, to systematically review CHIs.
CHIs Are Non-Linear and Produce ‘‘Irregular’’ Outcomes
CHIs are more than just a complicated ‘‘jumble’’ of
components that interact in a regularly predictable but linear
fashion (i.e., deterministically) to produce health outcomes.
Interactions between the components are not as deterministic as
might be expected because CHIs are highly dependent on human
behaviour [1,40]. The ‘‘components’’ in CHIs are invariably made
up of people (e.g., researchers) trying to get other people (e.g.,
study participants) to ‘‘do’’ or ‘‘not do’’ something (e.g., to stop
smoking in a CHI of smoking cessation). The actions taken by the
‘‘human components’’ of CHIs are influenced by the context in
which the intervention takes place. Taking the example of smoking
cessation, the actions that smokers can take will depend on their
personal circumstances, including their health status, while the
actions the clinic staff can take will be guided by factors such as the
trial protocol and the clinical setting.
Thus the context in which CHIs take place is a key variable,
because context influences and limits the range of people’s choices
and actions. Such context explains why the interactions between the
components of CHIs are not deterministic and why the outcomes of
CHIs can vary when the CHI is repeated. There will be a myriad of
different contexts, each having a slightly different influence on those
involved in the intervention. Human behaviour varies under the
influence of different contexts—and so the pattern of health
outcomes achieved from CHIs are best described as ‘‘demi-regular’’.
Box 1. Presentation of Review Findings: Information To Support Assessment of the Applicability of
Evidence of Effectiveness
Intervention Content [1]
N Describe the content (the active ingredients) of the
interventions
N Describe any interventions received by the control group,
including the content of ‘‘usual care’’
N Describe how the interventions were delivered and any
differences in delivery across the included trials
N Describe the contextual similarities and differences be-
tween the trials
Intervention Fidelity
N Include details describing whether the interventions
included in a review do what is intended or if they deviate
from the intended shape or form during the course of
implementation
N Include an assessment of whether an intervention failed
because it was poorly implemented or it was not effective
Intervention Sustainability
N Include details on the sustainability of intervention effects
over time
Roll Out/Scaling Up of the Intervention [7]
N Report data on accessibility, the risk of adverse events,
cost-effectiveness, or budget impact of interventions
N Address the following questions regarding the applicability
of the evidence to individual patients (where applicable)
[37]:
– Have biological results (e.g., sex, co-morbidities, age) that
might modify the treatment response been excluded?
– Can consumers comply with the treatment requirements?
– Can health care providers comply with the treatment
requirements?
– Are the likely benefits worth the potential risks and costs?
N Address the following questions regarding the applicability
of the evidence in other health systems (where applicable)
[38]:
– Are there important differences or similarities in the structural
elements of health systems or of health services between where
the research was done and where it will be applied that might
mean that an intervention could not work in the same way?
– Are there important differences in on-the-ground realities and
constraints (i.e., governance, financial, and delivery arrange-
ments) between where the research was done and where it
could be applied that might substantially alter the potential
benefits of the intervention?
– Are there likely to be important differences in the baseline
conditions between where the research was done and other
settings? If so, would this mean that the intervention could
have different absolute effects, even if the relative effectiveness
was the same?
– Are there important differences in perspectives and influences
of health system stakeholders between where the research was
done and where it could be applied that might mean an
intervention will not be accepted or taken up in the same way?
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Shepperd and colleagues rightly point out that the systematic
review of CHIs remains challenging. From the range of solutions
they have proposed, the greatest progress is likely to be made by
focusing on theories (Box 2) that can explain and ‘‘predict’’ how
certain contexts influence individuals to act in certain ways to
produce certain outcomes. Pawson and colleagues have already
made some progress towards such explanation and ‘‘prediction’’
using the ‘‘realist review’’ method of systematic review [41].
Realist Review
Realist review is a systematic review method that focuses more
on trying to explain as opposed to judge CHIs. As such, it seeks not
so much to answer the question of ‘‘If’’ a CHI works, but ‘‘How’’,
‘‘Why’’, ‘‘In what circumstances’’, ‘‘For whom’’, and ‘‘To what
extent’’ it works. The underlying premise of realist review is that
the demi-regular patterns of interactions between the components
(so-called ‘‘demi-regularities’’) that make up CHIs with similar
goals can be explained by middle-range theory (Box 2) [42]. For
any similar group of CHIs (e.g., smoking cessation interventions),
the myriad of contexts influencing behaviour so as to generate
outcomes are not impediments to realist review, but act as the
‘‘raw materials’’ from which demi-regularities can be identified.
Middle-range theory (or theories) are then sought to explain why
these demi-regularities occur. As the review progresses iteratively,
theories that ‘‘work’’ (i.e., best explain sets of demi-regularities) are
repeatedly ‘‘tested’’ against the observations reported in each CHI
included in the realist review [41,43,44].
In exploring the feasibility of systematically reviewing studies
that evaluate CHIs, I believe we have come to a crossroads.
Currently, the dominant systematic review methodology and
paradigm is based on the Cochrane review. Without doubt, its
dominance has been well earned as its usefulness in the systematic
review and meta-analysis of pharmaceutical and other ‘‘simpler’’
medical interventions has advanced the evidence-based practice of
medicine. However, efficacy studies of pharmaceutical studies are
less reliant on the human agency that we see in CHIs. In other
words, a well-characterised ‘‘drug’’ does things to people to cause
outcomes in a deterministic way, and context is much less relevant.
Once human agency comes into play (as can be seen in the
differences in outcomes reported between pharmaceutical efficacy
and effectiveness trials), then context starts to play a bigger role. By
the time we come to CHIs (where outcomes are highly dependent
Table 2. Current guidance for reporting complex interventions and where further research is required.
Reporting Tool [6]
Guidance for Reporting
the Characteristics of an
Intervention Gaps
Where Further Research Is Needed To Improve the Reporting
and Synthesis of the Effects of Complex Interventions
CONSORT for non-pharmacologic
treatments such as surgery,
technical interventions,
rehabilitation, psychotherapy,
behavioural interventions,
implantable and non-implantable
devices, and complementary
medicine (extension of the
CONSORT statement for reporting
randomised controlled trials)
Details of the intervention
and the experience of the
care provider for therapist-
dependent interventions
Does not address
fidelity or external
validity; can be applied
in a non-systematic
fashion
Individual Studies
N Systematise the description of complex interventions in trial reports as
well as in the reports of studies using other evaluation designs
N Ensure that more attention is given in reporting to issues of
intervention fidelity and external validity, such as the characteristics of
interventions, the health care system, and the setting and
implementation
N Increase the use of qualitative and quantitative process evaluations
alongside trials
N Ensure that the development of interventions for new trials is better
informed by the findings of existing systematic reviews and by existing
typologies and frameworks
QUOROM (Quality of Reports of
Meta-Analysis of Randomised
Controlled Trials)
Details of the intervention Does not provide
detailed guidance
Transparent Reporting of
Evaluations with Non-Randomized
Designs (TREND) [39] (developed
for reporting behavioural and public
health interventions)
Details of how and when
interventions were delivered,
the content, the delivery,
location, and setting, number
of sessions, time span, and
external validity
Provides the most
detailed guidance,
to be empirically
tested
Research Synthesis
N Formalise methods to identify and disaggregate the key elements and
effects of a complex intervention within a systematic review to
complement existing systematic review methodology
N Refine methods to identify relevant qualitative data linked to trials
N Systematise the description of complex interventions in systematic
reviews
N Develop empirically based typologies of interventions, linked to their
hypothesised mechanisms of actions and effect, and test how well these
work
doi:10.1371/journal.pmed.1000086.t002
Box 2: Definitions of Theory
Theory:
There are multiple definitions for theory, and in this
Viewpoint article: ‘‘A theory is an attempt to organize the
facts—some ‘proven’, some more conjectural—within a
domain of inquiry into a structurally coherent system’’ [45].
Middle-Range Theory:
This is a theory that lies ‘‘…between the minor but
necessary working hypotheses that evolve in abundance
during day-to-day research and the all-inclusive systematic
efforts to develop a unified theory that will explain all the
observed uniformities of social behavior, social organiza-
tion and social change…
‘‘It is intermediate to general theories of social systems
which are too remote from particular classes of social
behavior, organization and change to account for what is
observed and to those detailed orderly descriptions of
particulars that are not generalized at all. Middle-range
theory involves abstractions, of course, but they are close
enough to observed data to be incorporated in proposi-
tions that permit empirical testing.’’ [42].
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on human agency), then the appropriateness of the current
dominant systematic review method needs to be questioned.
Conclusion
In CHIs, the action of individuals under specific contexts results
in outcomes. The way these outcomes result is neither determin-
istic nor regular, but can be explained and ‘‘predicted’’ by middle-
range theory. Systematically reviewing CHIs is only feasible when
the review method takes into account these properties, and theory-
driven reviews are our best bet.
Aziz Sheikh’s Viewpoint: Undertaking Meaningful
Systematic Reviews of Complex Interventions Is
Inherently Complex
The evaluation of complex interventions is increasingly
commonplace within health services research. It is therefore
important and timely that attention is given to reflecting critically
on how these studies can best be identified and appraised, and
their findings then synthesised and interpreted. The answer to the
somewhat rhetorical question of whether it is feasible to
systematically review studies of complex interventions is, at one
level at least, obvious. Many of the general principles of systematic
review methods can and indeed should be used when undertaking
systematic reviews of complex intervention studies in health care.
Sasha Shepperd and colleagues offer a number of useful
suggestions in this respect, including: (1) the need to use broad
search techniques in an attempt to identify and include studies that
may have been poorly indexed; (2) carefully defining and
describing the interventions being studied; and (3) a willingness
to consider narrative synthesis if studies are found to be too
heterogeneous to be synthesised quantitatively.
There are, however, a number of important conceptual and
practical challenges in undertaking such reviews. One key
consideration that is usefully highlighted by Geoff Wong is the
importance of studying contextual considerations, both in relation
to understanding the broader picture in which individual studies
have been conducted, and in order to make sense of how the
landscape has (often irrevocably) changed as a result of the
intervention being applied. Wong also helpfully discusses the
central importance of considering not only what was achieved in
relation to standard parameters of interest, such as effect size, but
also why this may have been achieved, i.e., a clear description of
the processes that the intervention has operated through in order
to achieve this effect [46]. This latter consideration is particularly
important in that it is these processes that are far more likely to
prove generalisable than the specifics of the intervention under
study [47].
Based on my experiences of conducting a number of complex
intervention trials and attempts at undertaking systematic reviews
of complex interventions, I am increasingly of the opinion that
there are a number of additional unresolved issues that warrant
more detailed reflection.
Considering first the definition and description of the interven-
tion, it is important that researchers not only describe the
intervention in detail, but also that they capture and describe
how the intervention may have evolved during the course of
delivering it. A somewhat extreme example of such a complex
health care intervention, but which should nonetheless illustrate
the point well, is the United Kingdom’s National Programme for
Information Technology. This programme is the largest non-
military information technology-based intervention in the world.
Over the course of its relatively short life course, the programme
has undergone re-branding, had several rounds of leadership
change and, more fundamentally, expanded its list of core
deliverables [48]. Such changes are often mirrored, albeit on a
smaller scale, in the health interventions that we more routinely
consider as complex interventions. The key issue here is that such
modifications should not be seen as compromising the fidelity of
the intervention. Instead, these modifications should be recorded
and described as fully as possible in order to allow readers to make
sense of what modifications were considered necessary and why,
and through so doing allowing readers to appreciate what was
actually delivered [1].
A second important consideration relates to what is and what is
not considered a complex intervention. Most interventions do
have a degree of complexity—even a ‘‘simple’’ aspirin effectiveness
trial has some complexity—because the processes through which
the delivery of the intervention leads to actual patient compliance
with the treatment is inevitably made up of ‘‘several interacting
components’’ [1]. Some argue that this in effect means that the
term ‘‘complex intervention’’ is somewhat meaningless. I would
take a somewhat different view, stressing that what we must not do
is take the other extreme of excluding from our frame of reference
interventions that are judged so complex that they are not
amenable to study through randomised controlled trial designs.
Many health policy initiatives, particularly those that are national
or supra-national, are inherently multi-faceted, such as national
legislation prohibiting smoking in public places and the National
Programme for Information Technology. Such programme-level
interventions are often not easily amenable to study using quasi-
experimental designs, but their evaluation remains important and
such interventions should also be studied through systematic
reviews.
My third point relates to the importance of elucidating the likely
mechanisms through which the effects of the intervention are
mediated [49]. Carefully theorised studies/interventions can help
greatly in this respect, as can accompanying embedded qualitative
work, particularly if it has a longitudinal dimension [50,51]. One
way forward is to assign greater weight to studies that have
described mechanisms, but a more general point is the importance
of searching for and including relevant theoretical and qualitative
work into complex intervention systematic reviews.
Considering then the question of meta-analysis, whilst this may
be appropriate in some systematic reviews of complex interven-
tions [52], meta-analysis may also often be somewhat inappropri-
ate. Instead, we should really be more interested in understanding
the ways in which local contextual considerations may have acted
as co-factors in helping shape delivery of the intervention, rather
than focusing on finding any overall summary effect of the
intervention. Such summary effects may tend to obscure rather
than enlighten [25]. Consider, for example, our phase III and IV
studies of the accessibility, acceptability, and effectiveness of a
telephone-based review service for hard-to-reach people with
asthma [53,54]. These studies could only have been possible in a
climate that has a well-developed information technology
infrastructure, including routine use of electronic health records,
values regular review of those with long-term conditions, and
rewards practitioners accordingly. Paying careful attention to such
crucial contextual influences allows readers to begin to assess the
role of co-factors in shaping delivery of the intervention and also in
assessing its likely generalisability.
The upshot of all of this is that systematic reviews of complex
health interventions can and should be done, but if they are to
shed more light than darkness, the systematic reviewers need
explicitly to consider doing two things. First, they should search for
and include relevant theoretical and qualitative work. Second,
where relevant, they should include data from a broader range of
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experimental study designs than is currently normally the case in
most Cochrane systematic reviews. Such an approach will in turn
necessitate development of better search strategies to locate this
non-trial literature and also the availability of techniques for the
quality assessment of such studies. Theory-driven analysis,
wherever possible, should also accompany the more conventional
quantitative syntheses, the emphasis on the latter being down-
played. If the Cochrane Collaboration can take a lead in
spearheading and supporting these developments, this would
represent a considerable service to this important and expanding
field of evidence synthesis.
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